Hemophilia News and Research

RSS
Hemophilia is a rare, inherited bleeding disorder in which your blood doesn’t clot normally. If you have hemophilia, you may bleed for a longer time than others after an injury. You also may bleed internally, especially in your knees, ankles, and elbows. This bleeding can damage your organs or tissues and, sometimes, be fatal.
Why we may never know whether the $56,000-a-year Alzheimer’s drug actually works

Why we may never know whether the $56,000-a-year Alzheimer’s drug actually works

New approach to gene therapy uses common pain reliever to fight against genetic diseases

New approach to gene therapy uses common pain reliever to fight against genetic diseases

Immune tolerance in hemophilia can be modulated by B cell activating factor

Immune tolerance in hemophilia can be modulated by B cell activating factor

CHOP researchers identify key target responsible for treatment failure in patients with hemophilia A

CHOP researchers identify key target responsible for treatment failure in patients with hemophilia A

Spark Therapeutics launches gene therapy clinical trial for late-onset Pompe disease

Spark Therapeutics launches gene therapy clinical trial for late-onset Pompe disease

New taxonomic classification of non-skeletal rare congenital disorders with impact on bone physiology

New taxonomic classification of non-skeletal rare congenital disorders with impact on bone physiology

New clinical practice guidelines on diagnosis, management of von Willebrand Disease

New clinical practice guidelines on diagnosis, management of von Willebrand Disease

NIH-funded study to test emergency treatment for devastating stroke in Memphis

NIH-funded study to test emergency treatment for devastating stroke in Memphis

Providing personalized care for bleeding disorders

Providing personalized care for bleeding disorders

Shielding stem cells with novel biomaterial can reduce heart attack damage

Shielding stem cells with novel biomaterial can reduce heart attack damage

New articles focus on recent developments in the field of health preference research

New articles focus on recent developments in the field of health preference research

A new cell-based gene therapy approach to better treat patients with hemophilia A

A new cell-based gene therapy approach to better treat patients with hemophilia A

GlobalData: Hematology tests can be a prognostic marker to predict severity of COVID-19 patients

GlobalData: Hematology tests can be a prognostic marker to predict severity of COVID-19 patients

2021 health plans granted leeway to limit consumers’ benefit from drug coupons

2021 health plans granted leeway to limit consumers’ benefit from drug coupons

Takeda to present data from three Hematology studies at WFH 2020

Takeda to present data from three Hematology studies at WFH 2020

Using gene therapy to help the body to make its own cancer drugs

Using gene therapy to help the body to make its own cancer drugs

COVID survivors’ blood plasma is a sought-after new commodity

COVID survivors’ blood plasma is a sought-after new commodity

With federal nod, consumers could lose the boost they get from drug ‘coupons’

With federal nod, consumers could lose the boost they get from drug ‘coupons’

'Living drug factories' could be used to achieve long-term treatment of chronic diseases

'Living drug factories' could be used to achieve long-term treatment of chronic diseases

FDA approves immune-modulating therapy for treatment of multiple sclerosis

FDA approves immune-modulating therapy for treatment of multiple sclerosis